- Home
- / Pieris Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Pieris Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$17
2024-10-29
Market Capitalization
$22.4 M
2024-10-29
Revenue
$42.8 M
FY, 2023
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.9M | 5.8M | 25.3M | 29.1M | 46.3M | 29.3M | 31.4M | 25.9M | 42.8M | |||
| Revenue growth, % | -45.4% | 98.9% | ||||||||||
| General and administrative expense | 525.0 | 8.4M | 8.9M | 17.6M | 18.4M | 18.4M | 16.7M | 16.6M | 16.4M | 16.9M | 5.9M | 15.8M |
| Operating expense total | 525.0 | 16.6M | 28.6M | 39.9M | 59.9M | 73.4M | 63.2M | 69.4M | 58.7M | 14.1M | 38.6M | |
| EBIT | (15.7K) | (13.7M) | (22.8M) | (14.6M) | (30.8M) | (27.2M) | (33.9M) | (51.8M) | (43.5M) | (29.8M) | (14.1M) | (38.6M) |
| EBIT margin, % | -466.6% | -390.3% | -57.7% | -105.9% | -58.7% | -115.7% | -167.8% | -69.5% | ||||
| Interest expense | 184.6K | 2.3K | 152.0K | 2.0M | 1.7M | 511.0K | 4.0K | 721.0K | 1.9M | 430.0K | 2.6M | |
| Pre tax profit | (13.9M) | (22.6M) | (16.5M) | (27.1M) | (25.5M) | (37.1M) | (45.7M) | (33.3M) | (24.5M) | (17.4M) | (41.7M) | |
| Income tax expense | 203.9K | 162.0K | 1.1M | (312.0K) | 164.0K | |||||||
| Net Income | (15.7K) | (14.1M) | (22.8M) | (17.6M) | (26.8M) | (25.5M) | (37.2M) | (44.6M) | (33.3M) | (24.5M) | (17.4M) | (41.7M) |
| EPS | (7.8) | (3.7) |